Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

STELLAR-3 and STELLAR-4 Investigators

Resultado de la investigación: Articlerevisión exhaustiva

190 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials'. En conjunto forman una huella única.

Nursing and Health Professions

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology